Pages that link to "Q35153859"
Jump to navigation
Jump to search
The following pages link to Current developments in cancer vaccines and cellular immunotherapy (Q35153859):
Displaying 50 items.
- Cancer immunotherapy: moving beyond current vaccines (Q24548229) (← links)
- Improved Endpoints for Cancer Immunotherapy Trials (Q24603112) (← links)
- Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma (Q24684238) (← links)
- Welcome to the Journal of Immune Based Therapies and Vaccines (JIBTV) (Q24794125) (← links)
- Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma (Q24808685) (← links)
- Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored (Q26865395) (← links)
- The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation (Q27024106) (← links)
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (Q27860650) (← links)
- Immune response against dying tumor cells (Q28271233) (← links)
- Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide (Q30436422) (← links)
- Overview of mimotopes and related strategies in tumor vaccine development (Q33389252) (← links)
- Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma (Q33738279) (← links)
- Chemokines as Cancer Vaccine Adjuvants. (Q33792344) (← links)
- GM-CSF signalling boosts dramatically IL-1 production (Q33988195) (← links)
- Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. (Q34097414) (← links)
- The immuno-oncology framework: Enabling a new era of cancer therapy (Q34284462) (← links)
- Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models (Q34360520) (← links)
- TNF-α and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors (Q34541424) (← links)
- Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes (Q34544058) (← links)
- Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization (Q34557233) (← links)
- Immunotherapy for lung cancers (Q34557611) (← links)
- Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines (Q34657707) (← links)
- Recent advances in cancer vaccines: an overview (Q34882348) (← links)
- Primer on Medical Genomics Part X: Gene Therapy (Q35577275) (← links)
- Peptide-based vaccines for cancer immunotherapy (Q35681508) (← links)
- T-cell-based immunotherapy of melanoma: what have we learned and how can we improve? (Q35728607) (← links)
- Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines (Q35774908) (← links)
- Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity (Q35887255) (← links)
- Immunotherapy treatments for small-cell lung cancer: past, present and future (Q35904003) (← links)
- Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? (Q35971517) (← links)
- Biomarkers in melanoma: stage III and IV disease. (Q36050541) (← links)
- Immunotherapy and immunoprevention of cancer: where do we stand? (Q36150524) (← links)
- Activation of antigen-presenting cells by DNA delivery vectors (Q36210847) (← links)
- Adoptive cellular therapy enhances the helper T cell response and reduces the number of regulatory T cells (Q36230808) (← links)
- Immunotherapy for gynaecological malignancies. (Q36239661) (← links)
- Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells? (Q36255729) (← links)
- Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel (Q36280722) (← links)
- Adenovirus as vehicle for anticancer genetic immunotherapy (Q36288930) (← links)
- Recent developments in therapeutic cancer vaccines. (Q36303938) (← links)
- Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells (Q36399108) (← links)
- The rationale for prophylactic cancer vaccines and need for a paradigm shift (Q36423899) (← links)
- De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. (Q36459332) (← links)
- 2015 Guidance on cancer immunotherapy development in early-phase clinical studies (Q36467378) (← links)
- Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells (Q36589866) (← links)
- Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer (Q36614184) (← links)
- Therapeutic cancer vaccines: the latest advancement in targeted therapy (Q36695629) (← links)
- Vaccines for lung cancer. (Q36780563) (← links)
- Cancer vaccines: Looking to the future (Q36866158) (← links)
- The immunoinformatics of cancer immunotherapy (Q36927645) (← links)
- KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity (Q36964813) (← links)